Methoxypoly(ethylene glycol) dimyristoyl glycerol
Has been registered, DMF 038025, CDE F20210000399
SINOPEG is serving pharmaceutical and medical device companies around the globe, with product presence in various pharmaceutical/device development pipeline (pre-clinical, clinical, and post authorization large scale supply). Our facility is ISO9001 and ISO13485 certified, and is operating according to ICH Q7A guidelines to produce products for pharmaceutical companies.
Please contact us at sales@sinopeg.com for PEG derivatives. Our online catalog or inventory may not listed or have all molecular weights and functional groups, which may be available by custom synthesis. Please contact us at sales@sinopeg.com for quotation and availability.
Custom synthesis & CMO services are available.
License is required from license holder.
Reference:
1. Bian X, Guo Q, Yau LF, et al. Berberine-inspired ionizable lipid for self-structure stabilization and brain targeting delivery of nucleic acid therapeutics. Nat Commun. 2025;16(1):2368. Published 2025 Mar 10. doi:10.1038/s41467-025-57488-0
2. Yufeng Zhang,Liuwei Zhang,Hui Gao,等.Multi-functional lipid nanoformulations for enhancing the efficacy of mRNA tumor vaccines by reversing tumor immunosuppressive microenvironment[J].Nano Today, 2025, 63.DOI:10.1016/j.nantod.2025.102757.
3. Shao X, Liu L, Weng C, et al. Leveraging an mRNA Platform for the Development of Vaccines Against Egg Allergy. Vaccines (Basel). 2025;13(5):448. Published 2025 Apr 24. doi:10.3390/vaccines13050448
